French updated recommendations in Stage I to III melanoma treatment and management

被引:22
作者
Guillot, B. [1 ]
Dalac, S. [2 ]
Denis, M. G. [3 ]
Dupuy, A. [4 ]
Emile, J. F. [5 ]
De La Fouchardiere, A. [6 ]
Hindie, E. [7 ]
Jouary, T. [8 ]
Lassau, N. [9 ]
Mirabel, X. [10 ]
Neumann, S. Piperno [11 ]
De Raucourt, S. [12 ]
Vanwijck, R. [13 ]
机构
[1] CHU Montpellier, Dermatol Dept, Montpellier, France
[2] CHU Dijon, Dermatol Dept, Dijon, France
[3] CHU Nantes, Lab Biochem, Nantes, France
[4] CHU Rennes, Dermatol Dept, Rennes, France
[5] Ambroise Pare Hosp, AP HP, Lab Pathol, Boulogne, France
[6] Ctr Leon Berard Lyon, Lab Pathol, Lyon, France
[7] CHU Bordeaux, Dept Nucl Med, Bordeaux, France
[8] CH Pau, Dermatol Dept, Pau, France
[9] Inst Gustave Roussy Villejuif, Dept Radiol, Villejuif, France
[10] Ctr Oscar Lambret Lille, Dept Radiotherapy, Lille, France
[11] Inst Curie, Paris, France
[12] 1 Ave 6 Juin,1945, F-14000 Caen, France
[13] Louvain Catholic Univ, Brussels, Belgium
关键词
CUTANEOUS MELANOMA;
D O I
10.1111/jdv.14064
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
As knowledge continues to develop, regular updates are necessary concerning recommendations for practice. The recommendations for the management of melanoma stages I to III were drawn up in 2005. At the request of the Societe Francaise de Dermatologie, they have now been updated using the methodology for recommendations proposed by the Haute Autorite de Sante in France. In practice, the principal recommendations are as follows: for staging, it is recommended that the 7th edition of AJCC be used. The maximum excision margins have been reduced to 2 cm. Regarding adjuvant therapy, the place of interferon has been reduced and no validated emerging medication has yet been identified. Radiotherapy may be considered for patients in Stage III at high risk of relapse. The sentinel lymph node technique remains an option. Initial examination includes routine ultrasound as of Stage II, with other examinations being optional in stages IIC and III. A shorter strict follow-up period (3 years) is recommended for patients, but with greater emphasis on imaging.
引用
收藏
页码:594 / 602
页数:9
相关论文
共 10 条
[1]  
ANDEM, 1995, ANN DERMATOL VENER S, V125, P250
[2]   Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma [J].
Avril, M. -F. ;
Bahadoran, P. ;
Cabaret, O. ;
Caron, O. ;
de la Fouchardiere, A. ;
Demenais, F. ;
Desjardins, L. ;
Frebourg, T. ;
Hammel, P. ;
Leccia, M. -T. ;
Lesueur, F. ;
Mahe, E. ;
Martin, L. ;
Maubec, E. ;
Remenieras, A. ;
Richard, S. ;
Robert, C. ;
Soufir, N. ;
Stoppa-Lyonnet, D. ;
Thomas, L. ;
Vabres, P. ;
Bressac-de Paillerets, B. .
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2015, 142 (01) :26-36
[3]   Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Dummer, R. ;
Hauschild, A. ;
Guggenheim, M. ;
Keilholz, U. ;
Pentheroudakis, G. .
ANNALS OF ONCOLOGY, 2012, 23 :86-91
[4]   Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma [J].
Dummer, Reinhard ;
Guggenheim, Merlin ;
Arnold, Andres W. ;
Braun, Ralph ;
von Moos, Roger .
SWISS MEDICAL WEEKLY, 2011, 141
[5]   Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2012 [J].
Garbe, Claus ;
Peris, Ketty ;
Hauschild, Axel ;
Saiag, Philippe ;
Middleton, Mark ;
Spatz, Alan ;
Grob, Jean-Jacques ;
Malvehy, Josep ;
Newton-Bishop, Julia ;
Stratigos, Alexander ;
Pehamberger, Hubert ;
Eggermont, Alexander M. .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (15) :2375-2390
[6]   Update to the recommendations for management of melanoma stages I to III [J].
Guillot, B. ;
Dalac, S. ;
Denis, M. G. ;
Dupuy, A. ;
Emile, J. -F. ;
De La Fouchardiere, A. ;
Hindie, E. ;
Jouary, T. ;
Lassau, N. ;
Mirabel, X. ;
Neumann, S. Piperno ;
De Raucourt, S. ;
Vanwijck, R. .
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2016, 143 (10) :629-652
[7]  
Marsden JR, 2010, BRIT J DERMATOL, V163, P238, DOI [10.1111/j.1365-2133.2010.09883.x, 10.1016/j.bjps.2010.07.006]
[8]  
Negrier S, MELANOME CUTANE, V6
[9]  
Negrier S, 2005, ANN DERMATOL VENE S2, V132, p10S3
[10]   Malignant Melanoma S3-Guideline "Diagnosis, Therapy and Follow-up of Melanoma" [J].
Pflugfelder, Annette ;
Kochs, Corinna ;
Blum, Andreas ;
Capellaro, Marcus ;
Czeschik, Christina ;
Dettenborn, Therese ;
Dill, Dorothee ;
Dippel, Edgar ;
Eigentler, Thomas ;
Feyer, Petra ;
Follmann, Markus ;
Frerich, Bernhard ;
Ganten, Maria-Katharina ;
Gaertner, Jan ;
Gutzmer, Ralf ;
Hassel, Jessica ;
Hauschild, Axel ;
Hohenberger, Peter ;
Huebner, Jutta ;
Kaatz, Martin ;
Kleeberg, Ulrich R. ;
Koelbl, Oliver ;
Kortmann, Rolf-Dieter ;
Krause-Bergmann, Albrecht ;
Kurschat, Peter ;
Leiter, Ulrike ;
Link, Hartmut ;
Loquai, Carmen ;
Loeser, Christoph ;
Mackensen, Andreas ;
Meier, Friedegund ;
Mohr, Peter ;
Moehrle, Matthias ;
Nashan, Dorothee ;
Reske, Sven ;
Rose, Christian ;
Sander, Christian ;
Satzger, Imke ;
Schiller, Meinhard ;
Schlemmer, Heinz-Peter ;
Strittmatter, Gerhard ;
Sunderkoetter, Cord ;
Swoboda, Lothar ;
Trefzer, Uwe ;
Voltz, Raymond ;
Vordermark, Dirk ;
Weichenthal, Michael ;
Werner, Andreas ;
Wesselmann, Simone ;
Weyergraf, Ansgar J. .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 :1-116